IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by Amalgamated Bank

Amalgamated Bank trimmed its position in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 6.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 34,696 shares of the medical research company's stock after selling 2,283 shares during the quarter. Amalgamated Bank's holdings in IQVIA were worth $8,222,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently made changes to their positions in the business. Catalyst Capital Advisors LLC purchased a new position in IQVIA during the 3rd quarter valued at about $101,000. Impax Asset Management Group plc grew its holdings in shares of IQVIA by 9.7% during the third quarter. Impax Asset Management Group plc now owns 1,793,010 shares of the medical research company's stock worth $423,885,000 after purchasing an additional 157,809 shares in the last quarter. QRG Capital Management Inc. grew its holdings in shares of IQVIA by 2.1% during the third quarter. QRG Capital Management Inc. now owns 6,190 shares of the medical research company's stock worth $1,467,000 after purchasing an additional 130 shares in the last quarter. Asset Management One Co. Ltd. grew its holdings in shares of IQVIA by 1.3% during the third quarter. Asset Management One Co. Ltd. now owns 71,077 shares of the medical research company's stock worth $16,843,000 after purchasing an additional 888 shares in the last quarter. Finally, National Pension Service grew its holdings in shares of IQVIA by 12.7% during the third quarter. National Pension Service now owns 435,067 shares of the medical research company's stock worth $103,098,000 after purchasing an additional 49,130 shares in the last quarter. 89.62% of the stock is currently owned by institutional investors.

IQVIA Price Performance

IQV stock traded down $3.57 during mid-day trading on Thursday, reaching $217.68. 1,771,527 shares of the company's stock were exchanged, compared to its average volume of 1,099,974. The company has a market cap of $39.51 billion, a price-to-earnings ratio of 28.57, a price-to-earnings-growth ratio of 2.15 and a beta of 1.51. The stock's 50 day moving average is $232.31 and its 200 day moving average is $229.48. The company has a debt-to-equity ratio of 1.76, a current ratio of 0.81 and a quick ratio of 0.81. IQVIA Holdings Inc. has a 12-month low of $190.20 and a 12-month high of $261.73.

Wall Street Analyst Weigh In

Several analysts have issued reports on IQV shares. Evercore ISI cut their target price on IQVIA from $270.00 to $265.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th. Truist Financial dropped their price objective on IQVIA from $286.00 to $265.00 and set a "buy" rating for the company in a research note on Monday. Jefferies Financial Group lowered IQVIA from a "buy" rating to a "hold" rating and dropped their price objective for the company from $266.00 to $242.00 in a research note on Wednesday, July 24th. Robert W. Baird dropped their price objective on IQVIA from $256.00 to $223.00 and set a "neutral" rating for the company in a research note on Friday, November 1st. Finally, Morgan Stanley dropped their price objective on IQVIA from $280.00 to $265.00 and set an "overweight" rating for the company in a research note on Monday. Four research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $259.13.

Insiders Place Their Bets

In other IQVIA news, insider Eric Sherbet sold 1,300 shares of the stock in a transaction that occurred on Tuesday, August 27th. The stock was sold at an average price of $246.33, for a total transaction of $320,229.00. Following the transaction, the insider now owns 19,536 shares in the company, valued at approximately $4,812,302.88. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is currently owned by company insiders.

IQVIA Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.